BRD4 Inhibitor-38
BRD4 Inhibitor-38 (Compound 25) is an orally active inhibitor of BRD4 with IC50 values of 3.64 μM and 0.12 μM against BRD4 BD1 and BRD4 BD2, respectively. BRD4 Inhibitor-38 also exhibits anti-inflammatory activity, with an IC50 value of 1.98 μM for inhibiting nitric oxide (NO) production[1].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain; Interleukin Related; TNF Receptor
Related Pathways
Apoptosis; Epigenetics; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
COC1=C2C(N=C(/C=C/C3=CC=C(OC)C=C3)NC2=O)=CC(OC)=C1
Molecular Formula
C19H18N2O4
Molecular Weight
338.36
References & Citations
[1]Chen S, et al. Marine natural product-inspired discovery of novel BRD4 inhibitors with anti-inflammatory activity[J]. European Journal of Medicinal Chemistry, 2024: 117193.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV740954 1.0 µg DNA
PIRC104 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 